Fredrik Ollila
PhD (Biochemistry)
Chief Executive Officer
BonAlive Biomaterials
Australia
Biography
Dr. Ollila has a cross-functional background. He obtained his doctorate in biochemistry from Åbo Akademi University, Finland and has also studied Marketing and Finance at the Business School in Turku, Finland. Between 2003 and 2006 he held several positions at Novartis Pharma AG in Basel, Switzerland with increasing levels of responsibility. Dr. Ollila managed the FiberLive technology at Vivoxid Ltd. between 2006 and 2008, and from March 2008 he was responsible for the Global Sales and Marketing of BonAlive® at Vivoxid Ltd. Dr. Ollila was the key architect in executing the management buy-out of the BonAlive® technology from Vivoxid Ltd in 2009 and he has been the CEO of the company since then.
Research Interest
Molecular Biology and Molecular Genetics
